Management of APRT deficiency focuses on reducing DHA accumulation. Allopurinol, a xanthine oxidase inhibitor, is commonly used to decrease the production of DHA by inhibiting the oxidation of adenine. In some cases, dietary modifications to limit purine intake may also be recommended. Early and effective treatment can prevent renal damage and improve quality of life.
